Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9ALJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,015
Award facts
- Contract value 100% obligated
- $18,015.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Dupixent 300 mg/2 mL pens with a contract ceiling value of $18,015.10. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions. This delivery order fulfills federal pharmaceutical supply needs for military and veteran healthcare systems through DLA's comprehensive medical supply chain operations. AmerisourceBergen's role as a major pharmaceutical distributor and federal healthcare solutions provider positions it as a critical vendor for the Defense Health Agency and other government health systems, supporting the military's medical readiness through the supply of specialized medications and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9ALJ?
SPE2DR26F9ALJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F9ALJ worth?
The government has obligated $18,015 on SPE2DR26F9ALJ.
Is contract SPE2DR26F9ALJ an order under another contract?
Yes. SPE2DR26F9ALJ is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9ALJ competed?
The extent of competition for SPE2DR26F9ALJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award